These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 6381974)

  • 21. Influence of recipient's HLA type on the outcome of renal transplantation.
    Forsberg B; Ekberg H; Johnson U
    Transplant Proc; 1992 Dec; 24(6):2463-5. PubMed ID: 1465832
    [No Abstract]   [Full Text] [Related]  

  • 22. Influence of HLA antigens of renal transplant recipients on graft survival.
    Alamartine E; Berthoux F; Acquart S; Lepetit JC
    Transplant Proc; 1992 Dec; 24(6):2461-2. PubMed ID: 1465831
    [No Abstract]   [Full Text] [Related]  

  • 23. [HLA-incompatibility and kidney transplant: a question of desensitization].
    Grosjean F
    G Ital Nefrol; 2011; 28(6):581. PubMed ID: 22167608
    [No Abstract]   [Full Text] [Related]  

  • 24. Synchronous transplantation of a kidney and duct-obliterated segmental pancreas: report of a case.
    Munda R; Alexander JW; First MR; Knowles HC; Weiss MA
    Transplant Proc; 1980 Dec; 12(4 Suppl 2):98-102. PubMed ID: 7013215
    [No Abstract]   [Full Text] [Related]  

  • 25. Status of renal transplantation. A clinical perspective.
    Rao KV
    Med Clin North Am; 1984 Mar; 68(2):427-53. PubMed ID: 6369032
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Selection and management of patients for renal transplantation.
    Colberg JE
    Surg Clin North Am; 1973 Jun; 53(3):685-701. PubMed ID: 4574945
    [No Abstract]   [Full Text] [Related]  

  • 27. Quality of serological donor HLA typing: analysis of graft survival by HLA in renal transplantation recipients treated with cyclosporine.
    Thorogood J; Schreuder GM; Persijn GG; van Rood JJ
    Transplant Proc; 1992 Dec; 24(6):2485-7. PubMed ID: 1465839
    [No Abstract]   [Full Text] [Related]  

  • 28. Risk factors of sensitization to human leukocyte antigen in end-stage renal disease patients.
    Hung SY; Lin TM; Chang MY; Wang HH; Lee YC; Ho LC; Chen YT; Hung CM; Liou HH
    Hum Immunol; 2014 Jun; 75(6):531-5. PubMed ID: 24607727
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Kidney transplantation.
    Scott D
    Aust Fam Physician; 1976 Jun; 5(5):695-702. PubMed ID: 791226
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The improving prognosis after kidney transplantation. New strategies to overcome immunologic rejection.
    Levey AS
    Arch Intern Med; 1984 Dec; 144(12):2382-7. PubMed ID: 6391406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal transplant rejection. Transient immunodominance of HLA mismatches.
    Gilks WR; Gore SM; Bradley BA
    Transplantation; 1990 Jul; 50(1):141-6. PubMed ID: 2368134
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Rescue therapy for early antibody mediated rejection with a proteasome inhibitor: a case report.
    Manitpisitkul W; Wilson N; Cooper M; Gurk-Turner C; Hurley H; Rasetto F; KuKuruga D; Barth RN; Philosophe B
    Clin Transpl; 2009; ():461-3. PubMed ID: 20524315
    [No Abstract]   [Full Text] [Related]  

  • 33. Clinical management of the PD patient after transplantation.
    Chiaramonte S; Dissegna D; Inguaggiato P
    Contrib Nephrol; 2003; (140):256-63. PubMed ID: 12800367
    [No Abstract]   [Full Text] [Related]  

  • 34. Graft and patient outcomes of zero-human leucocyte-antigen-mismatched deceased and live donor kidney transplant recipients.
    Lim WH; Gray NA; Chadban SJ; Pilmore H; Wong G
    Transpl Int; 2015 May; 28(5):610-8. PubMed ID: 25689280
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Febrile reactions during hemodialysis].
    Dutz W; Fabian R; Hiller R
    Z Urol Nephrol; 1973 Sep; 66(9):683-8. PubMed ID: 4593073
    [No Abstract]   [Full Text] [Related]  

  • 36. Renal allotransplantation in humans. Collective review and case reports.
    Arana VA; Menno AD
    Nebr State Med J; 1971 Aug; 56(8):327-43. PubMed ID: 4398273
    [No Abstract]   [Full Text] [Related]  

  • 37. The outlook for adolescents with chronic renal failure.
    Grushkin CM; Korsch BM; Fine RN
    Pediatr Clin North Am; 1973 Nov; 20(4):953-63. PubMed ID: 4584747
    [No Abstract]   [Full Text] [Related]  

  • 38. Community treatment of end-stage renal failure by dialysis and renal transplantation from cadaver donors.
    Sheil AG; Stewart JH; Johnson JR; May J; Storey BG; Rogers JH; Charlesworth JA; Wright R; Sharp A; Johnston JM; Sands JR; Loewenthal J
    Lancet; 1969 Nov; 2(7627):917-20. PubMed ID: 4186593
    [No Abstract]   [Full Text] [Related]  

  • 39. Circulating immune complexes in dialyzed patients waiting for renal transplantation.
    Benzonana G; Carpentier N; Jeannet M; Lambert PH; De Moerloose P; De Wurstemberger B; Leski M
    Transplant Proc; 1981 Sep; 13(3):1556-8. PubMed ID: 7303148
    [No Abstract]   [Full Text] [Related]  

  • 40. [Antibody response to histocompatibility antigens in hemodialysis patients subjected to planned whole-blood transfusions].
    Fagiolo U; Corsano A; Antonello A; Venturi-Pasini C; Dal Lago O; Indiveri F
    Minerva Chir; 1980 May; 35(10):701-4. PubMed ID: 7005724
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.